课题基金 / 基金详情

Targeting FtsZ for antibiotics discovery

Targeting FtsZ for antibiotics discovery
以 FtsZ 为目标进行抗生素发现
批准号:
17590409
负责人:
KIRIKAE Teruo
金额:
$2.37万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

KIRIKAE Teruo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We focused on the development of novel drugs against drug-resitant pathogens, including multidrug-resistant Mycobacterium tuberculosis (MDR-TB), methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VRE). The following two subprojects were undertaken.Screening of extracts from a marine microbial culture collection for inhibition of FtsZ action in M. tuberculosis: A bacterial tubulin homologue, FtsZ, is an essential cell division protein that polymerizes in a GTP-dependent manner, forming a cytokinetic ring, designated as the Z ring, at the septum site. Since inactivation of FtsZ or alteration of FtsZ assembly results in the inhibition of Z ring and septum formation, FtsZ is a promising target for new antimicrobial drug development. We screened 15,000 samples from extracts from marine microbial collection for FtsZ inhibitor. Consequently, 30 hit samples were obtained. These samples were fractionated by ethyl acetate and purified by reversed-ph … More ase HPLC. The structure of the purified sample was determined by NMR. Finally, we determined a novel compound with a strong bactericidal activity against MDR-TB.Screening of traditional herbal extracts for drug-resistant pathogens: It is believed that many traditional herbal tinctures had bactericidal activities. One hundred herbal tinctures were screened for the inhibition of bacterial growth of MRSA, VRE, and MDR-TB. A selection of the most active tinctures was crudely fractionated by solvent partition and purified by silica gel chromatography and TLC. Two highly active compounds were analogoues of acylated phloroglucinols and triketones. Therefore, a series of acylated phloroglucinols and triketones was synthesized and tested for activity against MRSA, VRE, and MDR-TB. A tetra-methylated triketone with a C12 side chain was the most active compound (MIC of around 1.0 μg/ml against MRSA) and was shown to stimulate oxygen consumption by resting cell suspensions, suggesting that the primary target was the cytoplasmic membrane. Less
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
Survey of human immunodeficiency virus (HIV)-seropositive patients with mycobacterial infection in Japan.
日本人类免疫缺陷病毒(HIV)血清阳性分枝杆菌感染患者的调查。
DOI: --
发表时间: 2005
期刊: J Infect. 51(5)
影响因子: --
作者: [Otsuka Y, Fujino T, Mori N, Sekiguchi J, Toyota E, Saruta K, Kikuchi Y, Sasaki Y, Ajisawa A, Otsuka Y, Nagai H, Takahara M, Saka H, Shirasaka T, Yamashita Y, Kiyosuke M, Koga H, Oka S, Kimura S, Mori T, Kuratsuji T, Kirikae T.]
通讯作者: Kirikae T.
Association of rpoB mutations with rifampicin resistance in Mycobacterium avium.
rpoB 突变与鸟分枝杆菌利福平耐药性的关联。
DOI: --
发表时间: 2006
期刊: Int. J. Antimicrob. Agents 27
影响因子: --
作者: [Obata, S.]
通讯作者: S.
Association of rpoB mutations with rifampicin resistance in Mycobacterium avium
rpoB 突变与鸟分枝杆菌利福平耐药的关联
DOI: --
发表时间: 2006
期刊: Int. J. Antimicrob. Agents. 27
影响因子: --
作者: [Obata, S.]
通讯作者: S.
DOI: 10.1021/jm050920y
发表时间: 2006-01-26
期刊: JOURNAL OF MEDICINAL CHEMISTRY
影响因子: 7.3
作者: [Huang, Q, Kirikae, F, Ojima, I]
通讯作者: Ojima, I
6
    Molecular epidemiology of drug-resistant Gram-negative pathogens in Myanmar
    Mycobacterial PE_PGRS62 gene is a virulence factor during tuberculosis.
    Identification of virulent factors related to rearrangement of skeleton Proteins in mycobacterial infections.
    AN IDENTIFICATION AND CHARACTERIZATION OF MENBRANE PROTEIN ASSOCIATED WITH CELL ACTIVATIONS LY BACTERIAL LIPOPOLYSACCHARIDES
    • 批准号:
      11670270
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      1999
    • 负责人:
      KIRIKAE Teruo
    • 依托单位:
    国内基金
    海外基金
    大肠杆菌细胞分裂蛋白ZapC促进FtsZ形成Z环的机制的研究
    • 批准号:
      JCZRQN202500646
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位:
    青钱柳苷K靶向细胞骨架蛋白FtsZ抗MRSA感染的机制研究
    • 批准号:
      82374120
    • 项目类别:
      面上项目
    • 资助金额:
      48万元
    • 批准年份:
      2023
    • 负责人:
      刘杰
    • 依托单位:
    靶向水稻白叶枯病菌FtsZ(XooFtsZ)蛋白的新型抑制剂的发现及结构优化
    • 批准号:
      --
    • 项目类别:
      --
    • 资助金额:
      35万元
    • 批准年份:
      2021
    • 负责人:
      周翔
    • 依托单位:
    靶向水稻白叶枯病菌FtsZ(XooFtsZ)蛋白的新型抑制剂的发现及结构优化
    • 批准号:
      32160661
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      35.00万元
    • 批准年份:
      2021
    • 负责人:
      周翔
    • 依托单位: